Reference Source

Polydex Pharmaceuticals, Ldt. · 66-41 · CANADA

For Polydex Pharmaceuticals, Ldt., import alert is 66-41; country is CANADA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Dextran Sulfate; product code is 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is Unknown Street , Montreal, QC CANADA, verified against its source on 2026-10-01.

Firm
Polydex Pharmaceuticals, Ldt. verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
CANADA verified
Address
Unknown Street , Montreal, QC CANADA verified
Date published
09/30/2009 verified
Product code
66 V - - 99 Miscellaneous Patent Medicines, Etc. verified
Product
Dextran Sulfate verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Polydex Pharmaceuticals, Ldt. Date Published : 09/30/2009 Unknown Street , Montreal, QC CANADA

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Product code and Product

66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 12/03/2019 Desc: Dextran Sulfate

— all from accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.